Latest news
Nanjing Leads Biolabs Co., Ltd. (9887.HK) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 06:34:16 GMTWhat Oblenio’s Phase I trial means for autoimmune drug discovery - Drug Target ReviewDrug Target Review · Wed, 05 Aug 2026 14:00:01 GMTLeads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 12:18:05 GMT